Quantitative Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $413K | Buy |
2,255
+641
| +40% | +$118K | 0.04% | 316 |
|
|
2025
Q4 | $284K | Buy |
+1,614
| New | +$264K | 0.03% | 359 |
|
|
2025
Q1 | – | Sell |
-8,918
| Closed | -$1.36M | – | 343 |
|
|
2024
Q4 | $1.36M | Buy |
+8,918
| New | +$1.5M | 0.1% | 164 |
|
|
2024
Q2 | – | Sell |
-21,371
| Closed | -$4.61M | – | 316 |
|
|
2024
Q1 | $4.61M | Buy |
+21,371
| New | +$5.01M | 0.27% | 68 |
|
|
2023
Q1 | – | Sell |
-10,611
| Closed | -$2.94M | – | 229 |
|
|
2022
Q4 | $2.94M | Buy |
+10,611
| New | +$3M | 0.56% | 37 |
|
|
2022
Q3 | – | Sell |
-13,832
| Closed | -$2.82M | – | 276 |
|
|
2022
Q2 | $2.82M | Sell |
13,832
-7,078
| -34% | -$1.45M | 0.43% | 67 |
|
|
2022
Q1 | $4.4M | Buy |
+20,910
| New | +$4.55M | 0.48% | 24 |
|
|
2021
Q4 | – | Sell |
-23,817
| Closed | -$6.74M | – | 262 |
|
|
2021
Q3 | $6.74M | Sell |
23,817
-5,778
| -20% | -$1.89M | 0.61% | 38 |
|
|
2021
Q2 | $10.2M | Buy |
29,595
+24,927
| +534% | +$7.55M | 0.93% | 26 |
|
|
2021
Q1 | $1.3M | Buy |
+4,668
| New | +$1.26M | 0.11% | 199 |
|
|
2020
Q2 | – | Sell |
-35,343
| Closed | -$11.2M | – | 514 |
|
|
2020
Q1 | $11.2M | Buy |
+35,343
| New | +$10.7M | 1.22% | 14 |
|
|
2019
Q4 | – | Sell |
-96,396
| Closed | -$22.4M | – | 627 |
|
|
2019
Q3 | $22.4M | Buy |
+96,396
| New | +$22.4M | 1.2% | 8 |
|
|
2018
Q2 | – | Sell |
-34,800
| Closed | -$9.53M | – | 735 |
|
|
2018
Q1 | $9.53M | Buy |
+34,800
| New | +$10.8M | 0.17% | 153 |
|
|
2017
Q4 | – | Sell |
-145,500
| Closed | -$45.6M | – | 754 |
|
|
2017
Q3 | $45.6M | Buy |
145,500
+110,500
| +316% | +$32.7M | 0.52% | 33 |
|
|
2017
Q2 | $9.5M | Buy |
+35,000
| New | +$9.25M | 0.14% | 187 |
|
|
2016
Q4 | – | Sell |
-6,800
| Closed | -$2.13M | – | 794 |
|
|
2016
Q3 | $2.13M | Buy |
+6,800
| New | +$2.01M | 0.07% | 300 |
|
|
2016
Q2 | – | Sell |
-6,600
| Closed | -$1.72M | – | 747 |
|
|
2016
Q1 | $1.72M | Sell |
6,600
-10,600
| -62% | -$2.8M | 0.08% | 291 |
|
|
2015
Q4 | $5.27M | Buy |
17,200
+300
| +2% | +$86.2K | 0.32% | 72 |
|
|
2015
Q3 | $4.93M | Buy |
16,900
+9,700
| +135% | +$3.2M | 0.37% | 66 |
|
|
2015
Q2 | $2.91M | Buy |
7,200
+4,700
| +188% | +$1.89M | 0.44% | 51 |
|
|
2015
Q1 | $1.05M | Sell |
2,500
-17,200
| -87% | -$6.78M | 0.1% | 191 |
|
|
2014
Q4 | $6.69M | Buy |
+19,700
| New | +$6.37M | 1.03% | 16 |
|
|
2014
Q1 | – | Sell |
-1,600
| Closed | -$447K | – | 546 |
|
|
2013
Q4 | $447K | Sell |
1,600
-18,900
| -92% | -$4.89M | 0.04% | 349 |
|
|
2013
Q3 | $4.93M | Buy |
20,500
+13,100
| +177% | +$2.93M | 0.44% | 43 |
|
|
2013
Q2 | $1.59M | Buy |
+7,400
| New | +$1.58M | 0.28% | 74 |
|
Other funds holding BIIB
VCM
VPM
Quantitative Investment Management's BIIB Position: Q1 2026 in Review
Quantitative Investment Management increased its Biogen (BIIB) stake by 40% in Q1 2026, buying an estimated $118K and bringing the position to 2,255 shares worth $413K. The position accounts for 0.04% of the portfolio, ranked #316.
Quantitative Investment Management first reported a position in BIIB in Q2 2013 and has held it in 25 quarters since. The position peaked at $45.6M in Q3 2017. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Quantitative Investment Management held 2,255 shares of Biogen worth $413K as of Q1 2026.
- Quantitative Investment Management bought 641 Biogen shares in Q1 2026, an estimated $118K.
- Biogen made up 0.04% of Quantitative Investment Management's portfolio in Q1 2026, its #316 holding.
- Quantitative Investment Management first reported a position in Biogen in Q2 2013 and has held it in 25 quarters since.
- Quantitative Investment Management's Biogen position peaked at $45.6M in Q3 2017.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.